Literature DB >> 36045819

In Response to Errors in Antibiotic sensitivity testing: Barking up the wrong tree.

Hassan Mumtaz1, Hassan Ul Hussain2, Shahzaib Ahmad3.   

Abstract

Entities:  

Year:  2022        PMID: 36045819      PMCID: PMC9422070          DOI: 10.1016/j.amsu.2022.104112

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
Dear Editor This is in response to a correspondence written “Errors in Antibiotic sensitivity testing: Barking up the wrong tree” [1] on my article published in Annals of Medicine & Surgery, titled “Twelve-year trend of Escherichia coli antibiotic resistance in the Islamabad population” [2]. Mr. Harit Kumar and Dr Nitin Kumar claim that Antibiotic susceptibility testing (AST) is a standardized procedure which need to be performed and interpreted as per the recommended guidelines like Clinical and Laboratory standards Institute (CLSI) or European Committee on Antimicrobial Susceptibility Testing (EUCAST). However, the authors in this study have not mentioned at all about any guidelines to conduct AST and interpretation of the result [3,4]. Antibiotic susceptibility testing (AST) was performed and interpreted as per the recommended guidelines from Clinical and Laboratory standards Institute (CLSI However, I acknowledge that it’s not mentioned in the study. The Correspondence Authors made another claim that we have wrongly chosen and documented the concentrations of different antibiotics (Table 1) which were tested against the Uro-pathogenic E. coli strains. Moreover, the authors have just mentioned the name of antibiotic groups like Aminoglycosides and Cephalosporins but there are several antibiotics in each group which may not be tested using the same concentration. For instance, the potency of Gentamicin and Amikacin varies from each other [1].
Table 1

CLSI/EUCAST recommended potency of antibiotics.

S. No.AntibioticsPotency as mentioned in present studyRecommended potency by CLSI/EUCAST
1.Amoxicillin/Clavulanic acid625mg/1 gm20/10 μg
2.Trimethoprim/Sulphamethoxazole160/800 mg1.25/23.75 μg
3.Aminoglycosides80mg/500 mgGentamicin- 10 μg Amikacin- 30 μg
4.Nitrofurantoin3 gm300 μg
5.Cephalosporins400 mg30 μg
6.Sulbactams1 gm/2 gmNot to be used alone
7.Fosfomycin100 mg200 μg
CLSI/EUCAST recommended potency of antibiotics. The values mentioned in the antibiotic concentration portions of the methods [2] are the concentrations that were to be given to the patients for their treatment in specified doses normally available at the pharmacy, as decided by the Primary Care Specialist/Urologist according to his judgement & patient's body weight. These concentrations were just mentioned in the study to let the readers & Clinicians know which antibiotics are prescribed routinely and the available doses in the consumer market [2]. Sulbactam, which is a beta-lactamase inhibitor and is recommended to be tested only in combination like Ampicillin-sulbactam etc., was tested alone and reported as 75% sensitive against Uro-pathogenic E. coli in 2021 in this study [1]. Sulbactam belongs to beta-lactamase inhibitor class and it was tested with Ampicillin and sulbactam. As well as sulbactam with Cephalosporins [2]. It's just a misunderstanding that authors have gone through. There are different methods of performing antimicrobial susceptibility testing like diffusion method, dilution method, diffusion and dilution method etc. whereas the authors have not mentioned the name of method, opted in this study [5,6]. Diffusion method was chosen for our study [2]. In conclusion the antibiotic susceptibility test (AST) was conducted and the results evaluated. Both Ampicillin and Sulbactam were evaluated for their beta-lactamase inhibitor properties. The concentrations of these antibiotics were only disclosed so that readers and doctors could see what antibiotics are commonly administered. I think it's just an author's misunderstanding, we used the diffusion method.

Ethical approval

Not applicable.

Sources of funding

Not applicable.

Author contribution

Dr Hassan Mumtaz, Dr Shahzaib Ahmed, Dr Hassan ul Hussain have equally contributed in writing the final manuscript.

Registration of research studies

Name of the registry: NA Unique Identifying number or registration ID: NA Hyperlink to your specific registration (must be publicly accessible and will be checked): NA

Guarantor

Not applicable.

Consent

Not applicable.

Declaration of competing interest

There is No conflict of interest.
  3 in total

Review 1.  Antimicrobial susceptibility testing: a review of general principles and contemporary practices.

Authors:  James H Jorgensen; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

Review 2.  In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models.

Authors:  A Schumacher; T Vranken; A Malhotra; J J C Arts; P Habibovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-04       Impact factor: 3.267

3.  Twelve-year trend of Escherichia coli antibiotic resistance in the Islamabad population.

Authors:  Kashif Bangash; Hassan Mumtaz; Mehwish Mehmood; Majid Ali Hingoro; Zoobia Z Khan; Ahmed Sohail; Sami Ullah; Durishahwar Maqbool; Neelum Jamal; Momina Sami Khan; Shahzaib Ahmad; Anum Sohail; Hassan Ul Hussain; Irfan Ullah
Journal:  Ann Med Surg (Lond)       Date:  2022-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.